Forte Biosciences, Inc. (FBRX) — Stock Score Summary

Forte Biosciences, Inc. (FBRX) has a MoatMap StockRank of 11/100 based on Quality (21/100), Value (34/100), and Momentum (37/100) factor scores. The current signal is STRONG SELL. Forte Biosciences is a micro-cap clinical-stage biotech with extremely low quality metrics (Q-score of 22) and high binary clinical trial risk.

Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for autoimmune and inflammatory diseases. The company's primary asset is FB-102, a proprietary therapeutic candidate designed to address significant unmet medical needs in immunology. It operates as a high-risk, high-reward biotechnology developer, leveraging scientific expertise to advance its pipeline through early-to-mid-stage clinical trials.

Key Financial Metrics

Price$17.00
Market Cap$425M
P/E (Forward)-3.85
Price/Book5.26
Return on Equity-188.4%
Return on Invested Capital-113.9%
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-31M

Forte Biosciences, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Forte Biosciences, Inc.’s (FBRX) StockRank?
MoatMap’s StockRank for Forte Biosciences, Inc. (FBRX) is 11/100, with a Strong Sell signal. It is a composite of Quality (21), Value (34), and Momentum (37) factor ranks across MoatMap’s 19,000+ stock universe.
Does Forte Biosciences, Inc. have an economic moat?
Forte Biosciences, Inc. (FBRX) has a Quality factor score of 21/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Forte Biosciences, Inc. a buy, hold, or sell?
MoatMap’s current signal for Forte Biosciences, Inc. (FBRX) is Strong Sell, based on a StockRank of 11/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Forte Biosciences, Inc. in?
Forte Biosciences, Inc. (FBRX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksFBRX deep dive reportAI ChampionsHow we score stocksSense-check another stock